A phase 3b, randomized, open-label study of the safety and efficacy of Dolutegravir or Efavirenz each administered with two NRTIs in HIV-1-infected antiretroviral therapy-naïve adults starting treatment for Rifampicin-sensitive tuberculosis

This is a Phase III b, randomized, open-label study describing the efficacy and safety of DTG…

Long-term cohort

This is a long-term, post study cohort of HIV-infected patients who previously participated in HIV-NAT study…

A randomized double-blind phase 2 study comparing the efficacy, safety, and tolerability of combination antivirals (Amantadine, Ribavirin, Oseltamivir) versus Oseltamivir for the treatment of influenza in adults at risk for complications

This is a multicentered, randomized double-blind phase 2 study that will assess the efficacy, safety, and…

Towards a functional cure for HBV: exploiting lessons from HIV-HBV co-infection

This study willtest the hypothesis that HBsAg & HBeAg seroconversion/loss in HIV-HBV co-infected individuals following antiviral…

Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for drug-sensitive Tuberculosis (TRUNCATE-TB)

This is a two-month regimens using novel combinations to augment treatment effectiveness for drug-sensitive tuberculosis (TB):…

A phase 3b, randomized, open-label study of the antiviral activity and safety of Dolutegravir compared to Lopinavir/Ritonavir both administered with dual nucleoside reverse transcriptase inhibitor therapy in HIV-1 infected adult subjects with treatment failure on first line therapy

This study is conducted to demonstrate non-inferior antiviral activity at 48 weeks of a dolutegravir (DTG)…

Peripheral Arterial Diseases among perinatally HIV-infected Thai adolescents

To assess the prevalences and incidences of peripheral arterial diseases among perinatally HIV-infected Thai adolescents

A randomized double-blind study comparing standard treatment versus placebo for the treatment of influenza in low risk adults

This is a randomized blinded study that will evaluate whether the standard treatment modifies viral shedding…

Thailand HIV/AIDS and infectious disease clinical trials unit

The Thai Red Cross AIDS Research Centre (TRCARC) HIV Treatment Clinical Research Site operates under the…

Gut microbiome and NASH in HIV

Description: n/a

A surveillance program for the detection of hepatitis B virus (HBV) resistance to tenofovir (TDF) in HIV-HBV co-infected patients

This is a prospective, observational study in a multi-centre, international cohort surveillance study for the detection…

Implementation for tuberculosis preventive therapy among latent tuberculosis infection in HIV-infected individuals using novel regimen of Isoniazid/Rifapentine daily (4 weeks) compared to Isoniazid/Rifapentine weekly (12 weeks)

This study is a multicenter, randomized, open-label, phase III clinical trial of INH/RPT (Isoniazid/Rifapentine) regimen administered…

Bictegravir/TAF/FTC in HIV/HBV co-infection

Description: n/a

Rifapentine-containing treatment shortening regimens for pulmonary tuberculosis: A randomized, open-label, controlled phase 3 clinical trial

The purpose of this study is to determine whether one or two four-month regimens of tuberculosis…

Human papillomavirus infection in perinatally HIV-infected adolescents in Asia

This is a longitudinal case-control study to monitor a cohort of perinatally HIV-infected and matched HIV–uninfected…